Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma
about
Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progressionRecent advances in targeting the autotaxin-lysophosphatidate-lipid phosphate phosphatase axis in vivoLysophosphatidic acid (LPA) signaling in human and ruminant reproductive tractLPA receptor signaling: pharmacology, physiology, and pathophysiology.Lysophospholipid receptor nomenclature review: IUPHAR Review 8.Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases.ATX-LPA receptor axis in inflammation and cancer.The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine.Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancerMAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells.The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastasesCARMA3: A novel scaffold protein in regulation of NF-κB activation and diseasesAutotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasisLoss of the BRCA1-interacting helicase BRIP1 results in abnormal mammary acinar morphogenesis.LPA(1) -induced migration requires nonmuscle myosin II light chain phosphorylation in breast cancer cellsInsights into the pharmacological relevance of lysophospholipid receptors.Aberrant expression and potential therapeutic target of lysophosphatidic acid receptor 3 in triple-negative breast cancers.Transgenic Expression of Human Lysophosphatidic Acid Receptor LPA2 in Mouse Intestinal Epithelial Cells Induces Intestinal Dysplasia.Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells.Expression of lysophosphatidic acid receptors and local invasiveness and metastasis in Chinese pancreatic cancers.Lysophosphatidic Acid Up-Regulates Hexokinase II and Glycolysis to Promote Proliferation of Ovarian Cancer CellsLPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis.Transcriptional and post-transcriptional mechanisms for lysophosphatidic acid-induced cyclooxygenase-2 expression in ovarian cancer cells.TRIP6 antagonizes the recruitment of A20 and CYLD to TRAF6 to promote the LPA2 receptor-mediated TRAF6 activation.Mammary Adipose Tissue-Derived Lysophospholipids Promote Estrogen Receptor-Negative Mammary Epithelial Cell Proliferation.The gep proto-oncogene Gα13 mediates lysophosphatidic acid-mediated migration of pancreatic cancer cells.Regulation of the LPA2 receptor signaling through the carboxyl-terminal tail-mediated protein-protein interactionsTherapeutic potential of autotaxin/lysophospholipase d inhibitors.Potential biomarkers in the sera of breast cancer patients from bahawalpur, pakistan.Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cellsRoles of LPA in ovarian cancer development and progression.Lysophosphatidic acid (LPA) and endothelial differentiation gene (Edg) receptors in human pancreatic cancer.Diverse effects of LPA receptors on cell motile activities of cancer cells.The role and therapeutic potential of the autotaxin-lysophosphatidate signalling axis in breast cancer.Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.G-protein-coupled receptor signaling and polarized actin dynamics drive cell-in-cell invasion.Progranulin stimulated by LPA promotes the migration of aggressive breast cancer cells.Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid.Lysophosphatidic acid transactivates both c-Met and epidermal growth factor receptor, and induces cyclooxygenase-2 expression in human colon cancer LoVo cells.
P2860
Q24616764-D21221C6-670C-4697-A7FF-AE4E508ED12FQ26741062-E46CB140-064C-4105-BF5E-9920589AAFB1Q26829938-B05388F9-24BE-4593-878C-FE1B5DEB4487Q33825153-54F76E39-7A28-4235-8747-6807579886BEQ34025135-D3905B57-A9F3-43BD-B2A3-8FB6C6AF8A63Q34148745-D7A8D913-87E6-4BD8-AAAD-30532602E705Q34199719-76703554-E479-4E08-988F-62EAC8C205D8Q34357465-E62981D0-E631-42B7-9BF0-5A2125BF7869Q34359284-C373DE6F-D785-48AE-AC74-595AEC878144Q34672741-41BDF1DB-03D2-4006-873F-1CE08C91E5BCQ34687134-829E50EF-032B-406C-8AAC-70F443FC00C6Q34878582-E10BF8E4-58A7-4646-B7FE-B766706E4327Q34980426-DB1E2DB4-E617-47A5-8315-0E44C33AB171Q34989634-A599E797-1B1D-42C6-A65D-1650BF772D89Q35046383-2F00B669-FB79-46D7-BBFF-FB51BF8DDDE9Q35853199-7CDB3B6D-7625-48D1-8DC9-05255C1615EEQ35908698-56B10B61-72C6-4B41-A715-9C76885AE91FQ36002122-A035AC5B-DEAD-4217-8D76-4DD370FB4996Q36127217-8B451741-10E2-4732-AE42-50C50CA82357Q36145321-3439A222-CF43-4512-8CFD-19B02CA4808DQ36177654-4CE3CF67-FA56-465F-BA18-154D88311F66Q36181402-55896BD0-7F35-4593-B24C-55738672518DQ36645398-5E404682-D46A-4A39-9125-8EC187C5BCC2Q36804966-641CA2D3-C964-44BC-A19C-43AE636A6702Q36849465-7719776D-A644-420F-896B-EC5CE551A232Q36863295-EA15FB00-671A-4D0D-B3C1-3DE94EBA66EFQ36941344-3E049442-E739-435F-8425-4A7D9EF4AA36Q36951961-78AA5ED2-D6D4-40FC-9A95-D561E089F6DCQ37049044-098DA16B-0D3B-4ECF-95EC-C969B762B74DQ37218912-059A491A-6EA1-45C2-A444-EF5449124482Q37289059-68A40B04-C7D6-44A2-8AEB-ACD7CC31C8E8Q37650618-AE47AF7A-CABC-4D5F-9AD4-16DC3EA2C0AEQ37899821-0F280FBB-CB78-45C3-B56E-61C3AB22FB4AQ38181530-A28FB73A-C2DD-46EB-BFD7-222411FCB213Q38246634-FA13008E-C470-45C2-8370-2966BAA6B7DFQ38660494-6C118C37-F649-4DA8-9C20-09661722CB4BQ38982568-D43559F7-7B23-42DB-A146-B152B79D21C4Q39427075-774EA27F-B419-4D8D-BD14-0303A1470722Q40289797-A7B48F3F-9BD6-4FBA-8E3E-41794B852CDEQ40359909-B9057CEB-D751-4D69-95A9-2418026C7376
P2860
Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma
@ast
Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma
@en
Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma
@nl
type
label
Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma
@ast
Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma
@en
Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma
@nl
prefLabel
Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma
@ast
Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma
@en
Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma
@nl
P2093
P2860
P3181
P356
P1476
Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma
@en
P2093
Akihiro Sako
Hirokazu Nagawa
Hiroyuki Arai
Joji Kitayama
Kotaro Hama
Makoto Ishikawa
P2860
P2888
P304
P3181
P356
10.1186/BCR935
P407
P50
P577
2004-01-01T00:00:00Z
P5875
P6179
1013222098